Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Chronic Pain Associated With Painful Diabetic Neuropathy Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
-
Checkpoint Inhibitor Refractory Cancer Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
-
Net Asset Value Restatement for Simplify DBi CTA Managed Futures Index ETF (SDMF)
-
Permian Basin Oil and Gas Growth Drives Accel Compression Expansion and ELGi Compressor Sales
-
Ten TRCP Videos, One Incomplete Picture of the Menhaden Fishery
-
JPMorganChase Files Form 10-Q for the Quarter Ended September 30, 2026
-
Oriental Culture Holding LTD Announces First Half Year of 2026 Unaudited Financial Results
-
Globe Takes Major Step Toward AI-Driven Services with Amdocs Data Modernization Program
-
Douglas Emmett Releases Third Quarter 2026 Earnings Results
-
Magyar Telekom Selects Amdocs to Deliver Billing Transformation and Catalog Modernization
-
Pulmonary Hypertension associated with Interstitial Lung Disease Market Size in the 7MM is projected to grow at a CAGR of 3.9% over the forecast period of 2026-2036 | DelveInsight
-
Paroxysmal Nocturnal Hemoglobinuria Market Size in the 7MM is projected to grow at a CAGR of 7.1% over the forecast period of 2026-2036 | DelveInsight
-
Major Depressive Disorder Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Incyte Corp, LEO Pharma, Asana BioSciences, Arcutis Biotherapeutics, Innovaderm
-
Mucopolysaccharidosis I Market Size in the 7MM is projected to grow at a CAGR of 8.6% over the forecast period of 2026-2036 | DelveInsight
-
Gene And Cell Therapies Targeting CNS Disorders Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight
-
EagleRock Announces Third Quarter 2026 Results
-
Global Industrial Reports Third Quarter 2026 Financial Results
-
Florida State University Announces Aerospace Research and Innovation Facility at The St. Joe Company's VentureCrossings® Enterprise Centre
-
Tidal Financial Group and GammaRoad Capital Partners Announce Closure of GMMA ETF
-
Prudential Financial, Inc. Announces Third Quarter 2026 Results
-
Oxbridge / SurancePlus / AI GridWorks to Attend and Speak at The PIPEs Conference 2026
-
Keith Dagostino Grant Launches Hofstra University Business Scholarship to Support Undergraduate Students Nationwide
-
AIG Delivers Strong Third Quarter Results
-
Bright MLS Integration with Ocusell Network Goes Live, Expanding Multi-MLS Publishing Across the Mid-Atlantic and Unveiling OneList Listing Platform
-
Postal Realty Trust, Inc. Reports Third Quarter 2026 Results
-
PCDJ releases DEX 4.1 with AI beat mapping and smarter track selection
-
Redwood Trust Plans C-Corporation Conversion and Preferred-for-Common Stock Exchange Offer at a Premium
-
Valmont to Participate in Baird’s 2026 Global Industrial Conference
-
Globe Expands Strategic Collaboration with Amdocs to Modernize Core Platforms and Strengthen IT Operations
-
Pantera Silver Announces Resumption of Trading on the TSX Venture Exchange
-
Kodak Reports Third-Quarter 2026 Financial Results
-
Omega Reports Third Quarter 2026 Results and Recent Developments
-
Matador Resources Company Reports Third Quarter 2026 Results Including Record Oil Production and Continued Debt Repayment
-
Fuel Tech Reports 2026 Third Quarter Financial Results; Outlines Framework for Sustainable Growth and Value Creation
-
LTC Reports 2026 Third Quarter Results as SHOP Momentum Continues
-
IFF Reports Third Quarter 2026 Results
-
RYAM Reports Third Quarter 2026 Results
-
Graft-Versus Host Disease Market Size, Share, Trends, and Growth Analysis: Strong Expansion Expected by 2034 | Syndax Pharma, Abbisko Therapeutics, Theriva Biologics, Seres Therapeutics, Cellestia Bio
-
Chronic Hand Eczema Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and Route of Administration Trends | Incyte Corp, LEO Pharma, Asana BioSciences, Arcutis Biotherapeutics
-
Polycythemia Vera Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Roche, Fujifilm Holdings Corp, Hangzhou Bensheng Pharma, Protagonist Therape
-
BK Virus Infection Market Is Set to Transform by 2036: Top Trends, Key Players, and Revenue Forecast Revealed | Ipsen, Memo Therapeutics, AlloVir, Veru Therapeutics, Memo Therapeutics, AiCuris
-
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Par Pacific Holdings Reports Third Quarter 2026 Results
-
Jack Henry & Associates, Inc. Reports First Quarter Fiscal 2027 Results
-
CPS Technologies Announces Third Quarter 2026 Financial Results
-
Dover to Present at the Baird 2026 Global Industrial Conference
-
NextNav to Participate in November 2026 Conferences
-
Jackson Announces Outstanding Third Quarter 2026 Results
-
Mosaic Announces Third Quarter 2026 Results
-
Sun Nuclear Debuts Simon, a Command Center for Linac Health in Radiation Oncology


